HSBC Holdings’s Celularity CELU Stock Holding History

HSBC Holdings’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-95,097	Closed	-$9.59M	–	2944
2021 Q1	$9.59M	Buy	+95,097	New	+$9.75M	0.01%	818

Other funds holding CELU

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

HSBC Holdings's CELU Position: Q2 2021 in Review

HSBC Holdings sold out of Celularity (CELU) in Q2 2021, closing a stake of 95,097 shares — an estimated $9.59M sold.

HSBC Holdings first reported a position in CELU in Q1 2021 and held it in 1 quarter. The position peaked at $9.59M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

HSBC Holdings reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
HSBC Holdings sold 95,097 Celularity shares in Q2 2021, an estimated $9.59M.
HSBC Holdings first reported a position in Celularity in Q1 2021 and held it in 1 quarter.
HSBC Holdings's Celularity position peaked at $9.59M in Q1 2021.
33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on HSBC Holdings's 13F filing for Q2 2021, filed 13 Aug 2021.